Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEfforia, Inc

About this trial

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

Eligibility criteria

Qualifiers

Age 18 years or older and able to provide informed consent.

Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.

Willing and able to take two capsules of Neuralli Mood daily for 90 days.

Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.

Disqualifiers

Pregnant or nursing.

Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.

Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.

Immunocompromised status or current immunosuppressive therapy.

Trial design

Treatments tested in this trial

  • Neuralli Mood

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Efforia, Inc

Lead sponsor

Bened Life

Collaborator